Amit B. Shah
CIK: 0001719077
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OTLC
Oncotelic Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Shah Amit B.
Shah Amit B. (SEC CIK 0001719077) files insider reports with the SEC as CFO of Oncotelic Therapeutics, Inc. (OTLC).
Signal8 holds 2 ownership filings by Shah Amit B., all Form 4s, filed between Jun 22, 2026 and Jul 14, 2026. Those filings report 2 transactions, from Jun 22, 2026 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shah Amit B.'s filings is in AGOURA HILLS, CA.
Recent filings by Shah Amit B.
Other insiders filing for Oncotelic Therapeutics, Inc. (OTLC)
- Trieu Vuong, CHAIRMAN AND CEO
- Fein Seymour Howard, CRO/CMO
- KING STEVEN W, Director
- MAIDA ANTHONY E III, DIRECTOR AND CMO - TRANS. MED.
- Saund Saran, CBO